Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat
Open Access
- 1 September 1989
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 104 (1-2) , 178-182
- https://doi.org/10.1016/0304-3940(89)90351-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicityJournal of Neuroscience, 1988
- (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primatesJAMA, 1988
- Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA)Toxicology and Applied Pharmacology, 1988
- New Data Intensify the Agony Over EcstasyScience, 1988
- Relationship between extracellular 5‐hydroxytryptamine and behaviour following monoamine oxidase inhibition and l‐tryptophanBritish Journal of Pharmacology, 1988
- MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neuronsPharmacology Biochemistry and Behavior, 1988
- Incidence of Recreational Use of 3,4-Methylenedimethoxymethamphetamine (MDMA, Ecstasy) on an Undergraduate CampusNew England Journal of Medicine, 1987
- Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of ratNeuropharmacology, 1987
- (±)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in ratsEuropean Journal of Pharmacology, 1987
- Characterization of [3H]paroxetine binding to rat cortical membranesEuropean Journal of Pharmacology, 1985